UiPath Inc. (NYSE:PATH) ranks among the top robotics to buy according to analysts. In line with its cautious approach toward the company, Truist Securities reaffirmed its Hold rating and $13 price target on UiPath Inc. (NYSE:PATH) on July 15. Analyst Terry Tillman adjusted the quarterly estimates for fiscal year 2026, lowered the second-quarter free cash flow expectations since they were “likely too aggressive post strong 1Q performance and in relation to Street.”
Pixabay/Public Domain
Additionally, citing likely mis-modeling between the two periods, Truist shifted its forecasts of subscription service revenue from the third quarter to the fourth quarter.
Truist’s primary projections for fiscal year 2026, such as total revenue, annualized renewal run-rate, non-GAAP operating income, and free cash flow, are still in line with company guidance and consensus Street expectations despite these changes.
The firm stated that UiPath Inc. (NYSE:PATH) is “making aggressive moves with its combination of automation robots, AI agents and orchestration in a single agnostic platform emphasizing security and governance.”
UiPath Inc. (NYSE:PATH) is a multinational software company specializing in robotic process automation (RPA). The company automates manual procedures by providing a workflow designer, recording capabilities, and visual programming tools. UIPath’s RPA facilitates the development, deployment, and control of software robots that mimic human behavior.
While we acknowledge the potential of PATH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PATH and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.
Disclosure: None. This article is originally published at Insider Monkey.